Lyell Immunopharma, Inc. · NASDAQ:LYEL
Seely Lynn sold 545 Lyell Immunopharma, Inc. shares (Form 4)
Traded Nov 10, 2026 · Filed Nov 12, 2026
On Nov 10, 2026, Seely Lynn (Director, President and CEO) sold 545 Lyell Immunopharma, Inc. shares at US$15.93 for US$8,682, leaving 63,354 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 545 shares
- Price
- US$15.93
- Value
- US$8,682
- Holding after
- 63,354 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock | Sale | 545 | US$15.93 | 63,354 | Direct |
Source
Download original · View original at SEC
Related
- Lyell Immunopharma, Inc.
- Seely Lynn
- Lyell Immunopharma, Inc. shareholders
- Form 4 · Seely Lynn · Aug 25, 2026
- Form 4 · Seely Lynn · Aug 11, 2026
- Form 4 · Seely Lynn · Jun 15, 2026
- Form 4 · Lee Gary K. · Nov 12, 2026
- Form 4 · Hill Stephen J. · Nov 12, 2026
- Form 4 · Bulis Veronica Sanchez · Nov 12, 2026
- Schedule 13G/A · ARCH Venture Fund IX, L.P. · Nov 10, 2026
- Form 4 · ARCH Venture Partners IX, LLC · Nov 5, 2026